Emerging Role for Tandem Mass Spectrometry in Detecting Congenital Adrenal Hyperplasia
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders caused by a deficiency of one of five enzymes required for the synthesis of cortisol and aldosterone. The most common type of CAH is 21-hydroxylase deficiency (21OHD), which is attributable to mutations in the gene CYP21 and a pseudogene, CYP21P, located on the short arm of chromosome 6. As with other genetic disorders, genotype does not always predict phenotype. The phenotypic spectrum associated with 21OHD ranges from asymptomatic to early onset (as early as the fourth day of life) of severe salt-wasting crisis characterized by hypotension and electrolyte abnormalities that, if uncorrected, lead to death. Increased androgenic steroids, attributable to accumulated precursors proximal to the enzyme defect, cause ambiguous genitalia in female infants, leading to earlier clinical evaluation in girls. Virilized infant boys, however, are not always recognized, and many will present with acute catastrophic symptoms. Approximately 70% of infants with classic 21OHD have the salt-wasting form.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293
Lacey, J. M., Minutti, C. Z., Magera, M. J., Tauscher, A. L., Casetta, B., McCann, M., Lymp, J., Hahn, S. H., Rinaldo, P., & Matern, D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.027193 · Cited by 216
Allen, D. B., Hoffman, G. L., Fitzpatrick, P., Laessig, R., Maby, S., & Slyper, A. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70321-4 · Cited by 153
Cited by
Forest, M. G. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh047 · Cited by 200
Development and Performance Evaluation of a Tandem Mass Spectrometry Assay for 4 Adrenal Steroids
Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Pattison, E. G., Owen, W. E., Bunker, A. M., & Meikle, A. W. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068445 · Cited by 125
Watson, M. S., Lloyd-Puryear, M. A., Mann, M. Y., Rinaldo, P., & Howell, R. R. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000223467.60151.02 · Cited by 93
Kösel, S., Burggraf, S., Fingerhut, R., Dörr, H. G., Roscher, A. A., & Olgemöller, B. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.042416 · Cited by 52
“The liquid chromatography–tandem mass spectrometry method, however, requires greater technical sophistication and expertise, which might not be readily available and applicable in many regional screening programs that use tandem mass spectrometry for screening of metabolic disorders (15, 16).”
BackgroundBertholf, R. L., Jialal, I., & Winter, W. E. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00054-8 · Cited by 5
Metadata
- Authors
- Marsden, D., & Larson, C. A.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-01
- Volume
- 50
- Issue
- 3
- Pages
- 467-468
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W1984578096
- Cited by
- 15
- References
- 4
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging Role for Tandem Mass Spectrometry in Detecting Congenital Adrenal Hyperplasia. https://app.cochat.ai/papers/10.1373/clinchem.2003.029744
- The paper
- Marsden, D., & Larson, C. A. (2004). Emerging Role for Tandem Mass Spectrometry in Detecting Congenital Adrenal Hyperplasia. Clinical Chemistry. https://doi.org/10.1373/clinchem.2003.029744
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.